Trials / Unknown
UnknownNCT03772535
Pharmacogenetics for Pain Management in Joint Replacement Patients
Using Pharmacogenetics to Structure Individual Pain Management Protocols for Joint Replacement Patients
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Anderson Orthopaedic Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the ability to use pharmacogenetic testing in a joint replacement practice to prescribe the most effective pain medicine for a specific patient.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Pharmacogenomics Testing | The doctor will use genetic test results to prescribe medications that are a most effective for subject. |
Timeline
- Start date
- 2018-12-03
- Primary completion
- 2021-06-01
- Completion
- 2021-12-01
- First posted
- 2018-12-11
- Last updated
- 2021-02-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03772535. Inclusion in this directory is not an endorsement.